Greetings and welcome to the first issue of The VAnguard News! It has been an exciting few months since the launch of the project and we take this opportunity to share some insights as well as details about the project. VAnguard is the NIHR Global Health Research Group on Vaccines for vulnerable people in Africa. It comprises a multidisciplinary group of vaccine researchers from East Africa and the UK, with expertise ranging from bioscience, social science and data analysis, to community engagement and research capacity building. Overall the project aims to identify modifiable structural, social, and biological determinants of impaired vaccine impact in vulnerable African communities and inform the development of integrated strategies to address these, and to promote health equity. In this issue, meet our vibrant team and the communities that we have engaged, and have already started working with towards achieving our ambitious health targets. We look forward to continued engagement with all our stakeholders and your contribution to our overall objective. Hope you enjoy the read!
